Clopidogrel and Rituxan drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Clopidogrel and Rituxan. Common interactions include drug ineffective among females and arthralgia among males.
The phase IV clinical study analyzes what interactions people who take Clopidogrel and Rituxan have. It is created by eHealthMe based on reports of 133 people who take Clopidogrel and Rituxan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
133 people who take Clopidogrel and Rituxan together, and have interactions are studied.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 71,812 Clopidogrel users for its effectiveness, alternative drugs and more.
What is Rituxan?
Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 56,292 Rituxan users for its effectiveness, alternative drugs and more.
Number of Clopidogrel and Rituxan reports submitted per year:
Clopidogrel and Rituxan drug interactions by gender *:
Clopidogrel and Rituxan drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel and Rituxan?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Clopidogrel and Rituxan:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Clopidogrel interactions:
Browse all interactions between Clopidogrel and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Rituxan interactions:
Browse all interactions between Rituxan and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel and rituximab (the active ingredients of Clopidogrel and Rituxan, respectively), and Clopidogrel and Rituxan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ambisome and Abdominal Distension - 4 seconds ago
- Symdeko and Maternal Exposure During Pregnancy - 7 seconds ago
- Renagel and Rocaltrol drug interaction - 18 seconds ago
- Furosemide and Aggression - 20 seconds ago
- Vivitrol and Hypoglycaemia Aggravated - 22 seconds ago
- Nasonex and Reversible Ischaemic Neurological Deficit - 27 seconds ago
- Elavil and Retinal Disorder - 37 seconds ago
- Elavil and Respiratory Tract Oedema - 37 seconds ago
- Foscavir and Pulmonary Oedema - 42 seconds ago
- Hygroton and Taste - Impaired - 43 seconds ago